Bone marrow mesenchymal stem cells (BMSCs) differentiate into chondrocytes under appropriate conditions, providing a method for the treatment of bone- and joint-related diseases. Previously, we found that mulberry (Morus nigra) promoted the chondrogenic differentiation of BMSCs. Although the mechanism of action and active ingredients remain unknown, several studies describe the involvement of micro-RNAs. We obtained BMSCs from the bone marrow of Sprague Dawley rats. Cell Counting Kit-8 assays showed that maclurin (25 μg/mL) treatment was not toxic to BMSCs, and compared with untreated controls, maclurin upregulated Sox9 and Col2a expression. Quantitative-PCR revealed that miR-203a-3p levels decreased significantly during chondrogenic differentiation of BMSCs promoted by maclurin. Compared with treatment with an miR-203a-3p inhibitor, miR-203a-3p mimic inhibited expression of Sox9 and Col2a as evidenced by immunofluorescence staining and Western blotting. Smad1 was identified as a key target gene of miR-203a-3p according to biological-prediction software, and miR-203a-3p negatively regulated its transcription and translation in the dual-luciferase reporter gene assay and Western blotting. Sox9 and Col2a expression was downregulated following transfection of short interfering Smad1 (siSmad1) plasmids into BMSCs. We elucidated how maclurin promotes the chondrogenic differentiation of BMSCs by regulating miR-203a-3p/Smad1, which provides a strategy for future exploration of osteoarthritis therapy through cell transplantation.
Get full access to this article
View all access options for this article.
References
1.
AignerT., SöderS., GebhardP.M., McAlindenA., and HaagJ. (2007). Mechanisms of disease: Role of chondrocytes in the pathogenesis of osteoarthritis—structure, chaos and senescence. Nat. Clin. Pract. Rheumatol. 3, 391–399.
2.
AkiyamaH., ChaboissierM.C., MartinJ.F., SchedlA., and de CrombruggheB. (2002). The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev. 16, 2813–2828.
3.
BannuruR.R., OsaniM.C., VaysbrotE.E., ArdenN.K., BennellK., Bierma-ZeinstraS.M.A., KrausV.B., LohmanderL.S., AbbottJ.H., BhandariM., BlancoF.J., EspinosaR., HaugenI.K., LinJ., MandlL.A., MoilanenE., NakamuraN., Snyder-MacklerL., TrojianT., UnderwoodM., and McAlindonT.E. (2019). OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthr. Cartil. 27, 1578–1589.
CaiB., LiX., WangY., LiuY., YangF., ChenH., YinK., TanX., ZhuJ., PanZ., WangB., and LuY. (2013). Apoptosis of bone marrow mesenchymal stem cells caused by homocysteine via activating JNK signal. PLoS One 8,e63561.
6.
CanadasR.F., PirracoR.P., OliveiraJ.M., ReisR.L., and MarquesA.P. (2018). Stem cells for osteochondral regeneration. Adv. Exp. Med. Biol. 1059, 219–240.
7.
CannellI.G., KongY.W., and BushellM. (2008). How do microRNAs regulate gene expression? Biochem. Soc. Trans. 36, 1224–1231.
8.
ChaoJ., LiP., and ChaoL. (2017). Kallistatin: Double-edged role in angiogenesis, apoptosis and oxidative stress. Biol. Chem. 398, 1309–1317.
9.
ChenH.O., ZhangL., TangZ.Y., and GongZ.M. (2018a). MiR-485-5p promotes the development of osteoarthritis by inhibiting cartilage differentiation in BMSCs. Eur. Rev. Med. Pharmacol. Sci. 22, 3294–3302.
10.
ChenX., ZhiX., WangJ., and SuJ. (2018b). RANKL signaling in bone marrow mesenchymal stem cells negatively regulates osteoblastic bone formation. Bone Res. 6, 418–425.
11.
CleggD.O., RedaD.J., HarrisC.L., KleinM.A., O'DellJ.R., HooperM.M., BradleyJ.D., BinghamC.O., 3rd, WeismanM.H., JacksonC.G., LaneN.E., CushJ.J., MorelandL.W., Schumacher JrH.R., OddisC.W., WolfeF., MolitorJ.A., YocumD.E., SchnitzerT.E., FurstD.E., SawitzkeA.D., ShiH., BrandtK.D., MoskowitzR.W., and WilliamsH.J. (2006). Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N. Engl. J. Med. 354, 795–808.
12.
CraftA.M., RockelJ.S., NartissY., KandelR.A., AlmanB.A., and KellerG.M. (2015). Generation of articular chondrocytes from human pluripotent stem cells. Nat. Biotechnol. 33, 638–645.
13.
CraftC.S., PietkaT.A., SchappeT., ColemanT., CombsM.D., KleinS., AbumradN.A., and MechamR.P. (2014). The extracellular matrix protein MAGP1 supports thermogenesis and protects against obesity and diabetes through regulation of TGF-β. Diabetes, 63, 1920–1932.
14.
de KroonL.M., NarcisiR., Blaney DavidsonE.N., ClearyM.A., van BeuningenH.M., KoevoetW.J., van OschG.J., and van der KraanP.M. (2015). Activin receptor-like kinase receptors ALK5 and ALK1 are both required for TGFβ-induced chondrogenic differentiation of human bone marrow-derived mesenchymal stem cells. PLoS One 10,e0146124.
15.
de KroonL.M., NarcisiR., van den AkkerG.G., VittersE.L., Blaney DavidsonE.N., van OschG.J., and van der KraanP.M. (2017). SMAD3 and SMAD4 have a more dominant role than SMAD2 in TGFβ-induced chondrogenic differentiation of bone marrow-derived mesenchymal stem cells. Sci. Rep. 7, S166–S167.
16.
de RieD., AbugessaisaI., AlamT., ArnerE., ArnerP., AshoorH., ÅströmG., BabinaM., BertinN., BurroughsA.M., CarlisleA.J., DaubC.O., DetmarM., DeviatiiarovR., FortA., GebhardC., GoldowitzD., GuhlS, HaT.J., HarshbargerJ., HasegawaA., HashimotoK., HerlynM., HeutinkP., HitchensK.J., HonC.C., HuangE., IshizuY., KaiC., KasukawaT., KlinkenP., LassmannT., LecellierC.H., LeeW., LizioM., MakeevV., MathelierA, MedvedevaY.A., MejhertN., MungallC.J., NomaS., OhshimaM., Okada-HatakeyamaM., PerssonH., RizzuP., RoudnickyF., SætromP., SatoH., SeverinJ., ShinJ.W., SwobodaR.K., TaruiH., ToyodaH., Vitting-SeerupK., WinteringhamL., YamaguchiY., YasuzawaK., YonedaM., YumotoN., ZabierowskiS., ZhangP.G., WellsC.A., SummersK.M., KawajiH., SandelinA., RehliM., FANTOMConsortium, HayashizakiY., CarninciP., ForrestA.R.R., and de HoonM.J.L. (2017). An integrated expression atlas of miRNAs and their promoters in human and mouse. Nat. Biotechnol. 35, 872–878.
17.
EbrahimiyanH., RezaeiN., VojdanianM., AslaniS., JamshidiA., and MahmoudiM. (2019). microRNA involvement in the regulation of survivin in peripheral blood mononuclear cells from rheumatoid arthritis patients. Int. J. Rheum. Dis. 22, 1107–1114.
18.
HaradaN., WatanabeY., SatoK., AbeS., YamanakaK., SakaiY., KanekoT., and MatsushitaT. (2014). Bone regeneration in a massive rat femur defect through endochondral ossification achieved with chondrogenically differentiated MSCs in a degradable scaffold. Biomaterials, 35, 7800–7810.
19.
HochbergM.C., AltmanR.D., AprilK.T., BenkhaltiM., GuyattG., McGowanJ., TowheedT., WelchV., WellsG., and TugwellP. (2012). American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res. (Hoboken), 64, 465–474.
20.
HouQ., HuangY., LuoY., WangB., LiuY., DengR., ZhangS., LiuF., and ChenD. (2017). MiR-351 negatively regulates osteoblast differentiation of MSCs induced by (+)-cholesten-3-one through targeting VDR. Am. J. Transl. Res. 9, 4963–4973.
21.
HsuM.N., HuangK.L., YuF.J., LaiP.L., TruongA.V., LinM.W., NguyenN.T.K., ShenC.C., HwangS.M., ChangY.H., HuY.C. (2020). Coactivation of endogenous Wnt10b and Foxc2 by CRISPR activation enhances BMSC osteogenesis and promotes calvarial bone regeneration. Mol. Ther. 28, 441–451.
22.
HuangR.Y., LiL., WangM.J., ChenX.M., HuangQ.C., and LuC.J. (2015). An exploration of the role of MicroRNAs in psoriasis: A systematic review of the literature. Medicine (Baltimore) 94,e2030.
23.
HuangW., LiK., LiuA., ChenD., and WangH. (2018). Effect of sinapine on H2O2-induced adipogenic differentiation of bone marrow mesenchymal stem cells (in Chinese). Chinese J. Pathophysiol. 44, 918–924.
24.
HwangY.S., OhS.W., and ParkS.H. (2019). Melanogenic effects of maclurin are mediated through the activation of cAMP/PKA/CREB and p38 MAPK/CREB signaling pathways. Oxid. Med. Cell. Longev. 2019,9827519.
25.
JamesS., FoxJ., AfsariF., LeeJ., CloughS., KnightC., AshmoreJ., AshtonP., PrehamO., HoogduijnM., De Almeida Rocha PonzoniR., HancockY., ColesM., and GeneverP. (2015). Multiparameter analysis of human bone marrow stromal cells identifies distinct immunomodulatory and differentiation-competent subtypes. Stem Cell Reports, 4, 1004–1015.
26.
JiangN., JiangX., ChenZ., SongX., WuL., ZongD., SongD., YinL., WangD., ChenC., BianX., and HeX. (2017). MiR-203a-3p suppresses cell proliferation and metastasis through inhibiting LASP1 in nasopharyngeal carcinoma. J Exp Clin Cancer Res. 36,138.
27.
JoC.H., LeeY.G., ShinW.H., KimH., ChaiJ.W., JeongE.C., KimJ.E., ShimH., ShinJ.S., ShinI.S., RaJ.C., OhS., and YoonK.S. (2014). Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: A proof-of-concept clinical trial. Stem Cells, 32, 1254–1266.
28.
KimC., and KeatingA. (2019). Cell therapy for knee osteoarthritis: Mesenchymal stromal cells. Gerontology, 65, 294–298.
29.
KokotkiewiczA., LuczkiewiczM., PawlowskaJ., LuczkiewiczP., SowinskiP., WitkowskiJ., BrylE., and BucinskiA. (2013). Isolation of xanthone and benzophenone derivatives from Cyclopia genistoides (L.) Vent. (honeybush) and their pro-apoptotic activity on synoviocytes from patients with rheumatoid arthritis. Fitoterapia, 90, 199–208.
30.
KozhemyakinaE., LassarA.B., and ZelzerE. (2015). A pathway to bone: Signaling molecules and transcription factors involved in chondrocyte development and maturation. Development, 142, 817–831.
31.
KroonL.M.G., DavidsonE.N.B., NarcisiR., FarrellE., KraanP.M.V., and van OschG. (2017). Activin and nodal are not suitable alternatives to TGFβ for chondrogenic differentiation of mesenchymal stem cells. Cartilage, 8, 432–438.
32.
LeL.T., SwinglerT.E., and ClarkI.M. (2013). Review: The role of microRNAs in osteoarthritis and chondrogenesis. Arthritis. Rheum. 65, 1963–1974.
33.
LeeY.J., JungO., LeeJ., SonJ., ChoJ.Y., RyouC., and LeeS.Y. (2018). Maclurin exerts anti-cancer effects on PC3 human prostate cancer cells via activation of p38 and inhibitions of JNK, FAK, AKT, and c-Myc signaling pathways. Nutr. Res. 58, 62–71.
34.
LiC., HuQ., ChenZ., ShenB., YangJ., KangP., ZhouZ., and PeiF. (2018a). MicroRNA-140 suppresses human chondrocytes hypertrophy by targeting SMAD1 and controlling the bone morphogenetic protein pathway in osteoarthritis. Am. J. Med. Sci. 355, 477–487.
35.
LiH., LiZ., PiY., ChenY., MeiL., LuoY., XieJ., and MaoX. (2020). MicroRNA-375 exacerbates knee osteoarthritis through repressing chondrocyte autophagy by targeting ATG2B. Aging, 12, 7248–7261.
36.
LiK.C., ChangY.H., YehC.L., and HuY.C. (2016). Healing of osteoporotic bone defects by baculovirus-engineered bone marrow-derived MSCs expressing MicroRNA sponges. Biomaterials, 74, 155–166.
37.
LiL., WangJ., ChauJ.F., LiuH., LiB., HaoA., and LiJ. (2013). Smad1 stabilization and delocalization in response to the blockade of BMP activity. Cell. Mol. Biol. Lett. 18, 340–354.
38.
LiX., GaoY., LiF., LiangA., XuZ., BaiY., MaiW., HanL., and ChenD. (2014). Maclurin protects against hydroxyl radical-induced damages to mesenchymal stem cells: Antioxidant evaluation and mechanistic insight. Chem. Biol. Interact. 219, 221–228.
39.
LiX., GuoL., LiuY., SuY., XieY., DuJ., ZhouJ., DingG., WangH., BaiY., and LiuY. (2017). MicroRNA-21 promotes osteogenesis of bone marrow mesenchymal stem cells via the Smad7-Smad1/5/8-Runx2 pathway. Biochem. Biophys. Res. Commun. 493, 928–933.
40.
LiuC., LiT., YangZ., LiuD., LiY., ZhouZ., and ZhangQ. (2018). Kartogenin enhanced chondrogenesis in cocultures of chondrocytes and bone mesenchymal stem cells. Tissue Eng. Part A. 24, 990–1000.
41.
LiuF., HataA., BakerJ.C., DoodyJ., CárcamoJ., HarlandR.M., and MassaguéJ. (1996). A human Mad protein acting as a BMP-regulated transcriptional activator. Nature, 381, 620–623.
ManiarK.H., JonesI.A., GopalakrishnaR., and VangsnessC.T.Jr. (2018). Lowering side effects of NSAID usage in osteoarthritis: Recent attempts at minimizing dosage. Expert. Opin. Pharmacother. 19, 93–102.
44.
MatsumotoT., OkabeT., IkawaT., IidaT., YasudaH., NakamuraH., and WakitaniS. (2010). Articular cartilage repair with autologous bone marrow mesenchymal cells. J. Cell. Physiol. 225, 291–295.
45.
MazzeiM., VascellariM., ZanardelloC., MelchiottiE., VanniniS., ForzanM., MarchettiV., AlbaneseF., and AbramoF. (2019). Quantitative real time polymerase chain reaction (qRT-PCR) and RNAscope in situ hybridization (RNA-ISH) as effective tools to diagnose feline herpesvirus-1-associated dermatitis. Vet. Dermatol. 30, 491-e147.
46.
McGonagleD., BaboolalT.G., and JonesE. (2017). Native joint-resident mesenchymal stem cells for cartilage repair in osteoarthritis. Nat. Rev. Rheumatol. 13, 719–730.
47.
NugentM. (2016). MicroRNAs: Exploring new horizons in osteoarthritis. Osteoarthr. Cartil. 24, 573–580.
48.
SainiS., MajidS., YamamuraS., TabatabaiL., SuhS.O., ShahryariV., ChenY., DengG., TanakaY., and DahiyaR. (2011). Regulatory role of mir-203 in prostate cancer progression and metastasis. Clin. Cancer Res. 17, 5287–5298.
49.
SasikumarK.P., ElavarasuS., and GadagiJ.S. (2012). The application of bone morphogenetic proteins to periodontal and peri-implant tissue regeneration: A literature review. J. Pharm. Bioallied Sci. 4, S427–S430.
50.
SongJ., JinE.H., KimD., KimK.Y., ChunC.H., and JinE.J. (2015). MicroRNA-222 regulates MMP-13 via targeting HDAC-4 during osteoarthritis pathogenesis. BBA Clin. 3, 79–89.
51.
SunH., HuangY., ZhangL., LiB., and WangX. (2018). Co-culture of bone marrow stromal cells and chondrocytes in vivo for the repair of the goat condylar cartilage defects. Exp. Ther. Med. 16, 2969–2977.
52.
SzychlinskaM.A., StoddartM.J., D'AmoraU., AmbrosioL., AliniM., and MusumeciG. (2017). Mesenchymal stem cell-based cartilage regeneration approach and cell senescence: Can we manipulate cell aging and function? Tissue Eng. Part B Rev. 23, 529–539.
53.
TangY., ZhengL., ZhouJ., ChenY., YangL., DengF., and HuY. (2018). miR-203-3p participates in the suppression of diabetes‑associated osteogenesis in the jaw bone through targeting Smad1. Int. J. Mol. Med. 41, 1595–1607.
54.
TaoL., ZengY., WangJ., LiuZ., ShenB., GeJ., LiuY., GuoY., and QiuJ. (2015). Differential microRNA expression in aristolochic acid-induced upper urothelial tract cancers ex vivo. Mol. Med. Rep. 12, 6533–6546.
55.
TewS.R., McDermottB.T., FentemR.B., PeffersM.J., and CleggP.D. (2014). Transcriptome-wide analysis of messenger RNA decay in normal and osteoarthritic human articular chondrocytes. Arthritis Rheumatol. 66, 3052–3061.
56.
WangZ.C., SunH.J., LiK.H., FuC., and LiuM.Z. (2014). Icariin promotes directed chondrogenic differentiation of bone marrow mesenchymal stem cells but not hypertrophy in vitro. Exp. Ther. Med. 8, 1528–1534.
57.
WeiA.S., CallaciJ.J., JuknelisD., MarraG., ToninoP., FreedmanK.B., and WezemanF.H. (2006). The effect of corticosteroid on collagen expression in injured rotator cuff tendon. J. Bone Joint. Surg. Am. 88, 1331–1338.
WuZ., QiuX., GaoB., LianC., PengY., LiangA., XuC., GaoW., ZhangL., SuP., RongL., and HuangD. (2018). Melatonin-mediated miR-526b-3p and miR-590-5p upregulation promotes chondrogenic differentiation of human mesenchymal stem cells. J. Pineal Res. 65,e12483.
60.
XieF., KovicB., JinX., HeX., WangM., and SilvestreC. (2016). Economic and humanistic burden of osteoarthritis: A systematic review of large sample studies. Pharmacoeconomics, 34, 1087–1100.
61.
ZhangG., SunY., WangY., LiuR., BaoY., and LiQ. (2016a). MiR-502-5p inhibits IL-1β-induced chondrocyte injury by targeting TRAF2. Cell. Immunol. 302, 50–57.
62.
ZhangY., ZhouS. Y., YanH. Z., XuD. D., ChenH. X., WangX. Y., WangX., LiuY. T., ZhangL., WangS., ZhouP.J., FuW.Y., RuanB.B., MaD.L., WangY., LiuQ.Y., RenZ., LiuZ., ZhangR., and WangY.F. (2016b). miR-203 inhibits proliferation and self-renewal of leukemia stem cells by targeting survivin and Bmi-1. Sci. Rep. 6,19995.
63.
ZhangZ., KangY., ZhangZ., ZhangH., DuanX., LiuJ., LiX., and LiaoW. (2012). Expression of microRNAs during chondrogenesis of human adipose-derived stem cells. Osteoarthr. Cartil. 20, 1638–1646.
64.
ZhaoC., WangY., JinH., and YuT. (2017). Knockdown of microRNA-203 alleviates LPS-induced injury by targeting MCL-1 in C28/I2 chondrocytes. Exp. Cell Res. 359, 171–178.
65.
ZhouZ., DuD., ChenA., and ZhuL. (2018). Circular RNA expression profile of articular chondrocytes in an IL-1β-induced mouse model of osteoarthritis. Gene, 644, 20–26.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
